PF-08046031
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-08046031, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors [Phase 1]